Amgen filed with the SEC regarding stock ownership, while its stock is listed on Nasdaq, and Truist Financial provided analyst reports.
1 report, 1 independent
Updated Jun 20
AI-generated analysis. Brind wrote this summary from the reports listed below. It can be wrong. Each section says how much you can rely on it, and the sources are linked so you can check.
What happened
Amgen filed with the SEC regarding stock ownership, while its stock is listed on Nasdaq, and Truist Financial provided analyst reports.
Who's involved
What this event is mainly aboutKeep exploring
The entities involved
-
Amgen
American multinational biopharmaceutical company
Nothing else this week.
-
Securities and Exchange Commission
government agency of the Philippines
- Required filings have been made with the Securities and Exchange Commission regarding institutional investment disclosures due to increased holdings in the iShares S&P Mid-Cap 400 Value ETF.
- The SEC developed a regulatory framework for Sukuk in Sri Lanka, coinciding with Fitch expecting growth in the Islamic finance industry and noting Amana Bank's status.
Related events
- Amgen Inc. trades on the NASDAQ stock exchange.
- Cantor Fitzgerald and other analyst firms issued ratings on Amgen stock, which is listed on the Nasdaq exchange.
- The market is reacting to the news of Novartis' drug trial failures, specifically impacting Amgen's stock performance on the Nasdaq exchange.
- Amgen filed required reports with the Securities and Exchange Commission on June 16, 2026.
- Amgen and Merck are currently competing against each other in the market for investor capital.